{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Moderate+Ulcerative+Colitis&page=9", "query": { "condition": "Moderate Ulcerative Colitis", "page": 9 }, "page_size": 10 }, "pagination": { "page": 9, "page_size": 10, "total_count": 235, "total_pages": 24, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Moderate+Ulcerative+Colitis&page=10&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Moderate+Ulcerative+Colitis&page=8&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-13T02:35:39.631Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03759041", "title": "A Study to Assess Efficacy and Safety of SER-287 in Adults With Active Mild-to-Moderate Ulcerative Colitis", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Ulcerative Colitis" ], "interventions": [ { "name": "Vancomycin Pre-Treatment", "type": "DRUG" }, { "name": "Placebo for Vancomycin Pre-Treatment", "type": "DRUG" }, { "name": "SER-287", "type": "DRUG" }, { "name": "Placebo for SER-287", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Seres Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 203, "start_date": "2018-12-19", "completion_date": "2021-10-13", "has_results": true, "last_update_posted_date": "2022-08-12", "last_synced_at": "2026-10-13T02:35:39.631Z", "location_count": 81, "location_summary": "Phoenix, Arizona • North Little Rock, Arkansas • La Jolla, California + 70 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "North Little Rock", "state": "Arkansas" }, { "city": "La Jolla", "state": "California" }, { "city": "Lancaster", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03759041" }, { "nct_id": "NCT00791557", "title": "Open Label Study for Adults With Pyoderma Gangrenosum and Inflammatory Bowel Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Pyoderma Gangrenosum", "Crohn's Disease", "Ulcerative Colitis", "Inflammatory Bowel Disease" ], "interventions": [ { "name": "Infliximab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University Hospitals Cleveland Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 2, "start_date": "2008-10", "completion_date": "2010-02", "has_results": true, "last_update_posted_date": "2016-11-02", "last_synced_at": "2026-10-13T02:35:39.631Z", "location_count": 1, "location_summary": "Cleveland, Ohio", "locations": [ { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT00791557" }, { "nct_id": "NCT07184996", "title": "An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Ulcerative Colitis" ], "interventions": [ { "name": "Duvakitug", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "16 Years to 80 Years" }, "enrollment_count": 980, "start_date": "2025-10-08", "completion_date": "2028-05-09", "has_results": false, "last_update_posted_date": "2026-08-20", "last_synced_at": "2026-10-13T02:35:39.631Z", "location_count": 118, "location_summary": "Peoria, Arizona • Scottsdale, Arizona • Tucson, Arizona + 101 more", "locations": [ { "city": "Peoria", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07184996" }, { "nct_id": "NCT07845487", "title": "A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Ulcerative Colitis (UC)", "Severe Ulcerative Colitis", "Moderate Ulcerative Colitis" ], "interventions": [ { "name": "PALI-2108", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Palisade Bio", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 204, "start_date": "2026-08-28", "completion_date": "2028-06", "has_results": false, "last_update_posted_date": "2026-09-29", "last_synced_at": "2026-10-13T02:35:39.631Z", "location_count": 30, "location_summary": "Sun City, Arizona • San Diego, California • Bristol, Connecticut + 27 more", "locations": [ { "city": "Sun City", "state": "Arizona" }, { "city": "San Diego", "state": "California" }, { "city": "Bristol", "state": "Connecticut" }, { "city": "Orlando", "state": "Florida" }, { "city": "Des Plaines", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT07845487" }, { "nct_id": "NCT03616821", "title": "Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Ulcerative Colitis", "IBD" ], "interventions": [ { "name": "Brazikumab", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 242, "start_date": "2018-08-07", "completion_date": "2023-10-23", "has_results": true, "last_update_posted_date": "2026-06-23", "last_synced_at": "2026-10-13T02:35:39.631Z", "location_count": 51, "location_summary": "Phoenix, Arizona • Tucson, Arizona • Little Rock, Arkansas + 42 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Chula Vista", "state": "California" }, { "city": "Lancaster", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03616821" }, { "nct_id": "NCT06127043", "title": "A Study of Efficacy and Safety of Rosnilimab in Subjects With Moderate to Severe Ulcerative Colitis (ROSETTA)", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Ulcerative Colitis" ], "interventions": [ { "name": "Rosnilimab", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AnaptysBio, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 132, "start_date": "2023-12-04", "completion_date": "2026-05", "has_results": false, "last_update_posted_date": "2025-10-03", "last_synced_at": "2026-10-13T02:35:39.631Z", "location_count": 25, "location_summary": "Phoenix, Arizona • Garden Grove, California • Lancaster, California + 20 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Garden Grove", "state": "California" }, { "city": "Lancaster", "state": "California" }, { "city": "Lancaster", "state": "California" }, { "city": "San Jose", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06127043" }, { "nct_id": "NCT02531126", "title": "An Extension Study of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Ulcerative Colitis" ], "interventions": [ { "name": "RPC1063", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Celgene", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 877, "start_date": "2015-12-02", "completion_date": "2024-12-19", "has_results": true, "last_update_posted_date": "2025-12-31", "last_synced_at": "2026-10-13T02:35:39.631Z", "location_count": 10, "location_summary": "Tucson, Arizona • Anaheim, California • Mission Hills, California + 7 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Anaheim", "state": "California" }, { "city": "Mission Hills", "state": "California" }, { "city": "Oak Lawn", "state": "Illinois" }, { "city": "Baton Rouge", "state": "Louisiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT02531126" }, { "nct_id": "NCT05507216", "title": "ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Ulcerative Colitis" ], "interventions": [ { "name": "ABX464", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Abivax S.A.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": null, "sex": "ALL", "summary": "16 Years and older" }, "enrollment_count": 636, "start_date": "2023-01-25", "completion_date": "2025-07-15", "has_results": true, "last_update_posted_date": "2026-09-10", "last_synced_at": "2026-10-13T02:35:39.631Z", "location_count": 46, "location_summary": "Birmingham, Alabama • Litchfield Park, Arizona • Little Rock, Arkansas + 39 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Litchfield Park", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Bakersfield", "state": "California" }, { "city": "Covina", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05507216" }, { "nct_id": "NCT04996797", "title": "A Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Moderately to Severely Active Ulcerative Colitis (MK-7240-005)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Ulcerative Colitis" ], "interventions": [ { "name": "Tulisokibart", "type": "DRUG" }, { "name": "Companion Diagnostic (CDx) Testing", "type": "DEVICE" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "DEVICE", "OTHER" ], "sponsor": "Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 178, "start_date": "2021-07-14", "completion_date": "2025-07-14", "has_results": true, "last_update_posted_date": "2026-09-01", "last_synced_at": "2026-10-13T02:35:39.631Z", "location_count": 29, "location_summary": "Mobile, Alabama • Phoenix, Arizona • Sun City, Arizona + 24 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Sun City", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04996797" }, { "nct_id": "NCT05784246", "title": "A Study of Mirikizumab (LY3074828) in Pediatric Participants With Moderately to Severely or Active Ulcerative Colitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Ulcerative Colitis" ], "interventions": [ { "name": "Mirikizumab IV", "type": "DRUG" }, { "name": "Mirikizumab SC", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "2 Years to 17 Years" }, "enrollment_count": 63, "start_date": "2023-11-22", "completion_date": "2026-05-01", "has_results": false, "last_update_posted_date": "2026-06-03", "last_synced_at": "2026-10-13T02:35:39.631Z", "location_count": 6, "location_summary": "San Francisco, California • Atlanta, Georgia • Indianapolis, Indiana + 3 more", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "St Louis", "state": "Missouri" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05784246" } ] }